Publication
The new SAMR merger compliance guidelines
On 11 September 2023, the State Administration for Market Regulation of China (SAMR) issued the Antimonopoly Compliance Guidelines for Concentrations of Undertakings (the Guidelines).
Publication | October 2015
Canada’s Patented Medicines Notice of Compliance Regulations (PM(NOC) Regulations) are loosely based on the U.S. Hatch-Waxman regime and are meant to link patent protection with the drug approval process. As required by the PM(NOC) Regulations, Health Canada maintains a Patent Register (similar to the U.S. Orange Book).
Read more (pdf 1,006kb)
Publication
On 11 September 2023, the State Administration for Market Regulation of China (SAMR) issued the Antimonopoly Compliance Guidelines for Concentrations of Undertakings (the Guidelines).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023